FDA Inspection
VIOSVIOS – FDA Inspection, Sep 14, 2023
Record Details
This FDA Inspection record concerns VIOS, with an inspection on September 14, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · a9f692dd-20e4-4d50-a84b-ef80da1cfa70
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1218025
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of VIOS
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 9, 2026 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
| February 15, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 3, 2017 | OAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 2, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 28, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for VIOS
- FDA Inspection 1326256 - 2026-07-09
- FDA Inspection 1043268 - 2018-02-15
- FDA Inspection 1003678 - 2017-02-03
- FDA Inspection 886244 - 2014-07-02
- FDA Inspection 732394 - 2011-06-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.